Skip to main content

Exome Asset Management LLC

SEC CIK
0002011932
Latest filing
Aug 14, 2026

ASND holding history

Ascendis Pharma A/S in every 13F filed by Exome Asset Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ASND overviewAll 13F holders of ASNDFull Q2 2026 holdings

Shares (Q2 2026)
6,573
Value
$1.75M
% of portfolio
1.1%
Quarters held
3
Since Q2 2024
Holdings of ASND by Exome Asset Management LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20266,573$1.75M1.1%+6,573NewHolders
Q4 20240$00.0%−43,849−100.0%Sold outHolders
Q3 202443,849$6.55M4.4%+23,849+119.2%AddedHolders
Q2 202420,000$2.73M2.4%+20,000NewHolders